Free Trial
NYSE:AFL

Aflac Q3 2025 Earnings Report

Aflac logo
$110.59 -0.16 (-0.15%)
Closing price 03:59 PM Eastern
Extended Trading
$111.54 +0.96 (+0.87%)
As of 05:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aflac EPS Results

Actual EPS
N/A
Consensus EPS
$1.77
Beat/Miss
N/A
One Year Ago EPS
N/A

Aflac Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Aflac Announcement Details

Quarter
Q3 2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Aflac Earnings Headlines

Claim Your Share of $5.39 BILLION in AI Equity Checks
The U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enforcing that means a $5.39 billion pot must be paid out to everyday Americans. See, virtually every AI model is built off stolen data...tc pixel
Aflac Incorporated: An Orange a Day Keeps the Smiles on Display
See More Aflac Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Aflac? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aflac and other key companies, straight to your email.

About Aflac

Aflac (NYSE:AFL) Inc. is a Fortune 500 insurance company best known for its supplemental health and life insurance products. Founded in 1955 by brothers John and Paul Amos, the company provides policyholders with benefits designed to help cover out-of-pocket expenses associated with accidents, illnesses and hospital stays. Aflac’s core offerings include cancer insurance, critical illness policies, disability coverage, dental and vision plans, and life insurance, all tailored to complement primary health coverage.

The company operates through two main segments: U.S. and Japan. In the United States, Aflac sells individual and employer-sponsored group policies via a network of independent brokers, agents and payroll deduction systems. In Japan, Aflac is one of the largest providers of individual medical and cancer insurance, distributing products through a unique door-to-door sales force as well as through banks and financial institutions.

Aflac’s international footprint began in 1974 with the launch of its Japanese operations, which now account for a majority of its premium income. Over the decades, the company has grown its product suite to address an aging population and rising medical costs, leveraging brand recognition—most notably its Aflac Duck advertising campaign—to maintain high levels of consumer awareness and trust.

Headquartered in Columbus, Georgia, Aflac employs tens of thousands of associates worldwide. Daniel P. Amos, the son of co-founder Paul Amos, has served as chairman and chief executive officer since the early 2000s. Under his leadership, Aflac has focused on innovation in claims processing, digital customer engagement and expanded distribution partnerships to support its mission of helping policyholders manage financial risk during medical events.

View Aflac Profile

More Earnings Resources from MarketBeat